DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
05.01.2015 14:46:54
|
DexCom Appoints Kevin Sayer As CEO - Quick Facts
(RTTNews) - DexCom, Inc. (DXCM) announced the appointment of Kevin Sayer, currently the Company's President and Chief Operating Officer, as President and Chief Executive Officer.
The company said Sayer will succeed Terry Gregg, who is transitioning to the role of Executive Chairman after more than seven years of service as DexCom's President and Chief Executive Officer.
Commenting on Sayer, the company stated that he has served as DexCom's President and Chief Operating Officer since January 2013, as President since June 2011, and as a board member since November 2007.
From April 2007 to December 2010, Sayer served as Chief Financial Officer of Biosensors International Group, Ltd., a medical technology company developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures. Previously, Sayer served as Chief Financial Officer of MiniMed, Inc. from 1994 until its acquisition by Medtronic, Inc. in 2001, DexCom noted.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
06.05.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 beendet die Sitzung mit Verlusten (finanzen.at) | |
06.05.25 |
Schwacher Wochentag in New York: So bewegt sich der NASDAQ 100 nachmittags (finanzen.at) | |
06.05.25 |
Handel in New York: NASDAQ 100 in der Verlustzone (finanzen.at) | |
06.05.25 |
NASDAQ Composite Index-Papier DexCom-Aktie: So viel hätten Anleger mit einem Investment in DexCom von vor 5 Jahren verloren (finanzen.at) | |
02.05.25 |
Gewinne in New York: Schlussendlich Pluszeichen im NASDAQ 100 (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: NASDAQ Composite zum Handelsende mit Zuschlägen (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: S&P 500 liegt letztendlich im Plus (finanzen.at) | |
02.05.25 |
Gewinne in New York: Das macht der S&P 500 am Nachmittag (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 76,03 | 0,93% |
|